• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

香豆素衍生物作为强效抗结核药物的研究进展。

A Review on Coumarin Derivatives as Potent Anti-tuberculosis Agents.

机构信息

Faculty of Pharmacy, Integral University, Kursi road, Lucknow 226026 (U.P.), India.

Hygia Institute Of Pharmaceutical Education And Research, Lucknow, India.

出版信息

Mini Rev Med Chem. 2022;22(7):1064-1080. doi: 10.2174/1389557521666210927124511.

DOI:10.2174/1389557521666210927124511
PMID:34579635
Abstract

BACKGROUND

Tuberculosis (TB) is an acute or chronic infectious disease caused by several species of Mycobacterium, collectively called tubercle bacilli or Mycobacterium tuberculosis complex. Around 10 million people get sick with tuberculosis (TB) each year. TB is the second leading cause of death today after HIV/AIDS. A serious problem in the context of MDR-TB is the extensively drug-resistant TB, which is an important reason for the restricted chemotherapy in TB. Therefore, there is a need to explore new antitubercular (anti-TB) agents. Coumarin is an oxygencontaining heterocyclic compound and can be widely found in many natural products, and many of them display diverse biological activities. The wide spectrum of activities of coumarin molecules has intrigued the scientists to explore the natural coumarins and their synthetic derivatives for their potential as anti-TB drugs.

OBJECTIVE

The objective of this review is to emphasize important coumarin analogs with anti-TB activities and their structure-activity relationships (SAR) for designing better anti-TB agents.

METHOD

Latest, authentic and published reports on various synthetic and natural coumarin derivatives and their anti-TB activities is being thoroughly studied and analyzed. The structural requirements of coumarins as anti-TB drugs have also been studied.

RESULT

Collection and compilation of reports on various synthetic and natural coumarin derivatives and their anti-TB activities are being performed.

CONCLUSION

The study provides the latest report on coumarin derivatives synthesized as anti-TB agent and whether their activity depends on structural changes or not.

摘要

背景

结核病(TB)是一种由几种分枝杆菌引起的急性或慢性传染病,统称为结核分枝杆菌或结核分枝杆菌复合群。每年约有 1000 万人患上结核病(TB)。结核病(TB)是继艾滋病病毒/艾滋病之后导致死亡的第二大原因。耐多药结核病(MDR-TB)的一个严重问题是广泛耐药结核病(XDR-TB),这是结核病(TB)化疗受限的重要原因。因此,需要探索新的抗结核(anti-TB)药物。香豆素是一种含氧杂环化合物,可广泛存在于许多天然产物中,其中许多具有多种生物活性。香豆素分子的广泛活性引起了科学家的兴趣,他们探索天然香豆素及其合成衍生物作为潜在的抗结核(TB)药物。

目的

本综述的目的是强调具有抗结核(TB)活性的重要香豆素类似物及其构效关系(SAR),以设计更好的抗结核(TB)药物。

方法

对各种合成和天然香豆素衍生物及其抗结核(TB)活性的最新、真实和已发表的报告进行了彻底的研究和分析。还研究了香豆素作为抗结核(TB)药物的结构要求。

结果

正在对各种合成和天然香豆素衍生物及其抗结核(TB)活性的报告进行收集和汇编。

结论

该研究提供了关于合成作为抗结核(TB)药物的香豆素衍生物的最新报告,以及它们的活性是否取决于结构变化。

相似文献

1
A Review on Coumarin Derivatives as Potent Anti-tuberculosis Agents.香豆素衍生物作为强效抗结核药物的研究进展。
Mini Rev Med Chem. 2022;22(7):1064-1080. doi: 10.2174/1389557521666210927124511.
2
Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.香豆素衍生物作为强效抗结核药物的药物研发进展。
Eur J Med Chem. 2015 Jul 15;100:257-69. doi: 10.1016/j.ejmech.2015.06.017. Epub 2015 Jun 9.
3
Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity.香豆素杂合衍生物作为有前途的抗结核治疗先导物:为展现抗结核活性进行结构设计的最新进展和关键方面。
Tuberculosis (Edinb). 2021 Mar;127:102050. doi: 10.1016/j.tube.2020.102050. Epub 2021 Jan 6.
4
Recent developments of coumarin-containing derivatives and their anti-tubercular activity.含香豆素衍生物的最新研究进展及其抗结核活性。
Eur J Med Chem. 2017 Aug 18;136:122-130. doi: 10.1016/j.ejmech.2017.05.004. Epub 2017 May 2.
5
Coumarin as a Privileged and Medicinally Important Scaffold in the Treatment of Tuberculosis.香豆素作为治疗结核病的重要药物支架。
Curr Top Med Chem. 2023;23(16):1489-1502. doi: 10.2174/1568026623666230330084058.
6
Structure-activity relationship of natural and synthetic coumarin derivatives against .天然和合成香豆素衍生物对. 的构效关系
Future Med Chem. 2020 Sep;12(17):1533-1546. doi: 10.4155/fmc-2018-0281. Epub 2020 Aug 21.
7
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
8
Current Insights into the Chemistry and Antitubercular Potential of Benzimidazole and Imidazole Derivatives.当前对苯并咪唑和咪唑衍生物的化学和抗结核潜力的深入了解。
Mini Rev Med Chem. 2021;21(5):643-657. doi: 10.2174/1389557520666201102094401.
9
Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.社论:结核杆菌药物靶点的现状与展望以及基于构效关系的抗结核药物设计
Curr Pharm Des. 2014;20(27):4305-6. doi: 10.2174/1381612819666131118203915.
10
Synthesis and structure-activity relationships of phenyl-substituted coumarins with anti-tubercular activity that target FadD32.苯取代香豆素类化合物的合成及抗结核活性与 FadD32 靶点的结构活性关系研究
Bioorg Med Chem Lett. 2013 Nov 15;23(22):6052-9. doi: 10.1016/j.bmcl.2013.09.035. Epub 2013 Sep 19.

引用本文的文献

1
Coumarin hybrids: dual-target candidates for future antimicrobial and antitubercular therapies.香豆素杂合物:未来抗菌和抗结核治疗的双靶点候选物。
Future Med Chem. 2025 May;17(10):1131-1142. doi: 10.1080/17568919.2025.2504331. Epub 2025 May 12.
2
Rifabutin loaded inhalable β-glucan microparticle based drug delivery system for pulmonary TB.利福布汀负载可吸入β-葡聚糖微颗粒的肺部结核给药系统。
Sci Rep. 2024 Jul 16;14(1):16437. doi: 10.1038/s41598-024-66634-5.